Share This Author
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
Widespread and sustained cognitive deficits in alcoholism: a meta‐analysis
The findings support the diffuse brain hypothesis and suggest that cognitive dysfunction may linger for up to an average of 1 year post‐detoxification from alcohol.
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis
Hypoalgesia in schizophrenia is independent of antipsychotic drugs: A systematic quantitative review of experimental studies
Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Cannabidiol in Humans—The Quest for Therapeutic Targets
Preliminary clinical trials suggest that high-dose oral CBD may exert a therapeutic effect for social anxiety disorder, insomnia and epilepsy, but also that it may cause mental sedation.
Cocaine and Cognition: A Systematic Quantitative Review
- S. Potvin, K. Stavro, É. Rizkallah, Julie Pelletier
- Psychology, BiologyJournal of addiction medicine
- 1 September 2014
These results suggest significant impairment across multiple cognitive domains in cocaine abusers, and that some of these deficits may be partially masked by the residual or acute withdrawal effects of cocaine.
Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients
A meta-analysis of negative symptoms in dual diagnosis schizophrenia
The results of this meta-analysis show that schizophrenia patients with a substance use disorder experience fewer negative symptoms than abstinent schizophrenia patients, suggesting either that substance abuse relieves the negative symptoms of schizophrenia or that the patients with fewernegative symptoms would be more prone to substance use disorders.